A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer
Clinical trial NCT04284761 · COMPLETED
Trial details
- NCT number
- NCT04284761
- Sponsor
- Alessa Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-11
- Primary completion
- 2023-05-03
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.